Table 3 Univariate covariance analysis of factors related to elevated CK and CK-MB.

From: Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study

Variables

CK

CK-MB

F

R2

Observed power

P

OR

95% CI

F

R2

Observed power

P

OR

95% CI

Lower

Upper

Lower

Upper

Group (PMDP/FDDP)

12.076

0.076

0.932

0.001

22.313

9.605

35.022

15.191

0.101

0.972

0.000

2.615

1.287

3.943

Sex

12.060

0.076

0.931

0.001

22.940

9.866

36.014

0.016

− 0.008

0.052

0.900

− 0.087

− 1.454

1.279

Age

0.022

− 0.013

0.053

0.882

1.016

− 12.477

14.508

1.754

0.006

0.260

0.188

0.910

− 0.450

2.270

Disease duration

0.796

− 0.006

0.143

0.374

6.126

− 7.466

19.718

0.908

0.000

0.157

0.343

0.676

− 0.729

2.082

Duration of current therapy

0.002

− 0.013

0.050

0.963

− 0.311

− 13.647

13.025

0.296

− 0.005

0.588

0.588

− 0.376

− 1.743

0.992

  1. The baseline level of CK or CK-MB was taken as a covariate.
Back to article page